
Ceftron S 500mg/250mg Injection
Marketer
Cablin Healthcare Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Ceftron S 500mg/250mg Injection
Ceftriaxone and Sulbactam injection (500mg/250mg) is a dual-action antibiotic. It's indicated for treating diverse bacterial infections by inhibiting microbial proliferation and halting infection progression. This medication must be administered only under a physician's direct supervision. Adherence to the prescribed dosage schedule is crucial; complete the entire course, even with symptom improvement, as premature cessation can compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or worsening side effects necessitate immediate medical attention. Seek immediate medical assistance for any allergic reactions (such as skin rashes, itching, swelling, or respiratory distress). Inform your doctor of all current medications, including over-the-counter drugs, before commencing treatment. Pregnant or lactating individuals should consult their physician prior to use. Alcohol consumption should be avoided due to the potential for increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration will support faster recovery. Your doctor may order blood tests or other diagnostic procedures to monitor the medicine's effects.
Uses of Ceftron S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Ceftron S 500mg/250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Ceftron S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ceftron S 500mg/250mg Injection:
The medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Ceftron S 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Ceftron S 500mg/250mg Injection, offer a dual-action approach to bacterial infection. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, hindering their ability to survive. Sulbactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Ceftron S 500mg/250mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Ceftron S (500mg/250mg) is typically deemed safe for use during pregnancy. Preclinical trials using animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human clinical trials are scarce.
Breast feedingCAUTION
The administration of Ceftron S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until the mother's course of treatment concludes and the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Ceftron S 500mg/250mg Injection may induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ceftron S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Individuals with severe hepatic impairment should use the 500mg/250mg Ceftron S Injection cautiously, potentially requiring dosage modification. Mild to moderate liver disease does not necessitate Ceftron S 500mg/250mg Injection dose alteration; however, physician consultation is advised in all cases.
What if you forget to take Ceftron S 500mg/250mg Injection :
Omit a Ceftron S 500mg/250mg Injection dose? Seek medical advice immediately.
Facts to Know About Ceftron S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
